As of 2025-05-17, the Fair Value of Regenicin Inc (RGIN) is -0.03 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of Regenicin Inc is -3,037,760.00%.
With the market price of 0.00 USD and our fair value calculation, Regenicin Inc (RGIN) is not a good investment. Investing in RGIN stocks now will result in a potential loss of 3,037,760.00%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 5Y Avg | |
| Net income | -0.56 | -0.76 | -0.56 | -0.67 | -0.64 | -0.64 |
| YoY growth | 42.60% | -35.67% | 26.22% | -19.84% | 4.67% | 3.60% |
| Market Cap (mil) | 0.00 |
| P/E | |
| Forward P/E | -x |
| EPS | -0.01 |
| Avg earnings growth rate | 3.60% |
| TTM earnings | -0.93 |